PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $230,617 | +5.7% | 5,651 | 0.0% | 0.13% | -23.4% |
| Q4 2022 | $218,185 | -99.9% | 5,651 | 0.0% | 0.18% | -32.2% |
| Q3 2022 | $300,577,000 | -8.8% | 5,651 | 0.0% | 0.26% | -2.6% |
| Q2 2022 | $329,453,000 | +62533.7% | 5,651 | -18.1% | 0.26% | -11.7% |
| Q1 2022 | $526,000 | -99.9% | 6,896 | +9.5% | 0.30% | +102.7% |
| Q4 2021 | $378,830,000 | +7.4% | 6,296 | 0.0% | 0.15% | +33.3% |
| Q3 2021 | $352,576,000 | -7.7% | 6,296 | 0.0% | 0.11% | 0.0% |
| Q2 2021 | $382,041,000 | -13.4% | 6,296 | 0.0% | 0.11% | -10.5% |
| Q1 2021 | $441,287,000 | +17.1% | 6,296 | 0.0% | 0.12% | +31.9% |
| Q4 2020 | $376,753,000 | – | 6,296 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |